Phoenix, AZ – Spatomics has signed an exclusive license agreement with Arizona State University (ASU) to commercialize the CFP™ technology for high-plex omics applications.
The company will begin to develop highly sensitive and high-plex spatial proteomics assays for immuno-oncology and neuroscience applications. An industrial’s first high throughput end-to-end fully automated spatial biology analyzer is also on the product roadmap, set to be revealed in mid-2024.
